|
Fernandez O, Montalban X, Aguera E, Aladro Y, Alonso A, Arroyo R, Brieva L, Calles C, Costa-Frossard L, Eichau S, Garcia-Dominguez JM, Hernandez MA, Landete L, Llaneza M, Llufriu S, Meca-Lallana JE, Meca-Lallana V, Mongay-Ochoa N, Moral E, Oreja-Guevara C, Ramio-Torrenta L, Tellez N, Romero-Pinel L, Rodriguez-Antiguedad A. [15th Post-ECTRIMS Meeting: a review of the latest developments presented at the 2022 ECTRIMS Congress (Part II)]. Rev Neurol. 2023 Jul 16;77(2):47-60. doi: 10.33588/rn.7702.2023168. Spanish. PubMed PMID: 37403243; PubMed Central PMCID: PMC10662183.
AÑO: 2023; IF: 0.8
|
37403243
|
Carreon Guarnizo E, Hernandez Clares R, Castillo Trivino T, Meca Lallana V, Arocas Casan V, Iniesta Martinez F, Olascoaga Urtaza J, Meca Lallana JE. Experience with tocilizumab in patients with neuromyelitis optica spectrum disorders. Neurologia (Engl Ed). 2022 Apr;37(3):178-183. doi: 10.1016/j.nrleng.2018.12.021. Epub 2021 Feb 26. PubMed PMID: 35465911.
AÑO: 2022
|
|
Meca-Lallana JE, Gomez-Ballesteros R, Perez-Miralles F, Forero L, Sepulveda M, Calles C, Martinez-Gines ML, Gonzalez-Suarez I, Boyero S, Romero-Pinel L, Sempere AP, Meca-Lallana V, Querol L, Costa-Frossard L, Prefasi D, Maurino J. Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients' Perspective: An Observational Cross-Sectional Study. Neurol Ther. 2022 Sep;11(3):1101-1116. doi: 10.1007/s40120-022-00356-6. Epub 2022 May 6. PubMed PMID: 35524037; PubMed Central PMCID: PMC9075919.
AÑO: 2022; IF: 3.7
|
|
Lopez-Soley E, Meca-Lallana JE, Llufriu S, Blanco Y, Gomez-Ballesteros R, Maurino J, Perez-Miralles F, Forero L, Calles C, Martinez-Gines ML, Gonzalez-Suarez I, Boyero S, Romero-Pinel L, Sempere AP, Meca-Lallana V, Querol L, Costa-Frossard L, Sepulveda M, Solana E. Cognitive Performance and Health-Related Quality of Life in Patients with Neuromyelitis Optica Spectrum Disorder. J Pers Med. 2022 May 2;12(5):743. doi: 10.3390/jpm12050743. PubMed PMID: 35629165; PubMed Central PMCID: PMC9146457.
AÑO: 2022; IF: 3.4
|
|
Carreon Guarnizo E, Hernandez Clares R, Castillo Trivino T, Meca Lallana V, Arocas Casan V, Iniesta Martinez F, Olascoaga Urtaza J, Meca Lallana JE. Experience with tocilizumab in patients with neuromyelitis optica spectrum disorders. Neurologia (Engl Ed). 2022 Apr;37(3):178-183. doi: 10.1016/j.nrl.2018.12.013. Epub 2019 Mar 28. English, Spanish. PubMed PMID: 30928236.
AÑO: 2022; IF: 2.283
|